Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL

Clinical trial NCT03502876 · COMPLETED

Trial details

NCT number: NCT03502876
Sponsor: French Innovative Leukemia Organisation
Status: COMPLETED
Study type: OBSERVATIONAL

B Cell Chronic Lymphocytic Leukemia

Start date: 2017-11-02
Primary completion: 2018-12-31
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.